Manhattan West Asset Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.81M Buy
10,374
+1,411
+16% +$420K 0.55% 50
2025
Q4
$2.96M Sell
8,963
-1,254
-12% -$425K 0.61% 46
2025
Q3
$3.53M Buy
10,217
+123
+1% +$37.2K 0.75% 41
2025
Q2
$3.15M Buy
10,094
+4,797
+91% +$1.83M 0.73% 41
2025
Q1
$2.77M Buy
5,297
+312
+6% +$159K 0.71% 44
2024
Q4
$2.52M Buy
4,985
+224
+5% +$127K 0.68% 46
2024
Q3
$2.78M Buy
4,761
+95
+2% +$53.7K 0.72% 46
2024
Q2
$2.38M Sell
4,666
-1,803
-28% -$884K 0.64% 50
2024
Q1
$3.2M Buy
6,469
+955
+17% +$486K 0.77% 47
2023
Q4
$2.9M Buy
5,514
+3,056
+124% +$1.63M 0.81% 38
2023
Q3
$1.28M Buy
2,458
+1,369
+126% +$674K 0.39% 66
2023
Q2
$523K Buy
1,089
+617
+131% +$302K 0.2% 92
2023
Q1
$223K Buy
+472
New +$228K 0.1% 118

Other funds holding UNH

Manhattan West Asset Management's UNH Position: Q1 2026 in Review

Manhattan West Asset Management increased its UnitedHealth (UNH) stake by 16% in Q1 2026, buying an estimated $420K and bringing the position to 10,374 shares worth $2.81M. The position accounts for 0.55% of the portfolio, ranked #50.

Manhattan West Asset Management first reported a position in UNH in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.53M in Q3 2025. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Manhattan West Asset Management held 10,374 shares of UnitedHealth worth $2.81M as of Q1 2026.
  • Manhattan West Asset Management bought 1,411 UnitedHealth shares in Q1 2026, an estimated $420K.
  • UnitedHealth made up 0.55% of Manhattan West Asset Management's portfolio in Q1 2026, its #50 holding.
  • Manhattan West Asset Management first reported a position in UnitedHealth in Q1 2023 and has held it in 13 quarters since.
  • Manhattan West Asset Management's UnitedHealth position peaked at $3.53M in Q3 2025.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Manhattan West Asset Management's 13F filing for Q1 2026, filed 14 May 2026.